|
gptkbp:instanceOf
|
patent
|
|
gptkbp:covers
|
pharmaceutical compositions
|
|
gptkbp:description
|
treatment methods
|
|
gptkbp:hasAbstract
|
This patent describes a method for treating a disease using specific compounds.
|
|
gptkbp:hasApplicationNumber
|
10/123,456
|
|
gptkbp:hasAssignee
|
Company XYZ
|
|
gptkbp:hasCapital
|
cancer treatment
|
|
gptkbp:hasCitedPatent
|
US_5,678,901
Journal_of_Medical_Research,_2003.
|
|
gptkbp:hasClaim
|
20
|
|
gptkbp:hasClimate
|
treatment of chronic diseases.
|
|
gptkbp:hasCollaboratedWith
|
University_ABC.
|
|
gptkbp:hasCollaborationsWith
|
XYZ_Research_Institute.
|
|
gptkbp:hasDescription
|
The invention relates to a novel method for treating diseases.
|
|
gptkbp:hasExaminer
|
Jane_Smith
|
|
gptkbp:hasExhibition
|
show efficacy in animal models.
|
|
gptkbp:hasFieldOfUse
|
medical treatment
|
|
gptkbp:hasFilingDate
|
2004-02-06
|
|
gptkbp:hasFilm
|
nausea
|
|
gptkbp:hasFunding
|
gptkb:National_Institutes_of_Health
|
|
gptkbp:hasImpactOn
|
high.
|
|
gptkbp:hasInternationalClassification
|
514/123
C07D 401/12
|
|
gptkbp:hasInventor
|
gptkb:John_Doe
|
|
gptkbp:hasLegalStatus
|
active
|
|
gptkbp:hasLocalCuisine
|
NCT01234567
|
|
gptkbp:hasMerchandise
|
inhibits specific enzymes.
|
|
gptkbp:hasOccupation
|
FDA_approved.
|
|
gptkbp:hasPartnershipsWith
|
licensed.
|
|
gptkbp:hasPatentNumber
|
6,789,040
|
|
gptkbp:hasPerformedAt
|
oral
|
|
gptkbp:hasPriorityDate
|
2024-02-06
2003-02-06
|
|
gptkbp:hasPrograms
|
favorable
|
|
gptkbp:hasPublications
|
2004-09-14
|
|
gptkbp:hasRelatedPatent
|
biotechnology.
utility patent.
US 10/987,654.
|
|
gptkbp:hasResearchInterest
|
pharmaceutical sciences
published in 2020.
combination therapies.
in vitro testing
|
|
gptkbp:hasSibling
|
PCT application.
|
|
gptkbp:hasTechnicalField
|
biochemistry
|
|
gptkbp:hasTechnology
|
improved efficacy.
|
|
gptkbp:hasTitle
|
Method for treating a disease
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,040 C61
|
|
gptkbp:inventiveStep
|
novel compound.
|
|
gptkbp:isAssignedTo
|
Company XYZ
|
|
gptkbp:isCitedBy
|
gptkb:US_7,123,456
US_8,765,432.
|
|
gptkbp:isFiledIn
|
gptkb:United_States
|
|
gptkbp:isFiledUnder
|
US patent law.
|
|
gptkbp:isGranted
|
true
|
|
gptkbp:isIncorporatedIn
|
clinical guidelines.
|
|
gptkbp:isPartOf
|
patent family
patent portfolio.
therapeutic regimen.
|
|
gptkbp:isPublishedIn
|
gptkb:US_2004/0187654_A1
USPTO_database.
|
|
gptkbp:isRecognizedBy
|
scientific community.
|
|
gptkbp:isRelatedTo
|
gptkb:US_6,123,456
gptkb:US_6,789,041_C61
|
|
gptkbp:isSubjectTo
|
patent litigation.
|
|
gptkbp:isSupportedBy
|
clinical evidence.
|
|
gptkbp:isTargetedAt
|
specific disease pathways.
|
|
gptkbp:isUsedIn
|
clinical settings.
|
|
gptkbp:market
|
available.
high.
|